BTG4 Antibody

Code CSB-PA878918LA01HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human ovarian cancer using CSB-PA878918LA01HU at dilution of 1: 100

  • Western Blot
    Positive WB detected in: Mouse brain tissue
    All lanes: BTG4 antibody at 3μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 26, 25 kDa
    Observed band size: 26 kDa

  • Immunohistochemistry of paraffin-embedded human testis tissue using CSB-PA878918LA01HU at dilution of 1:100

Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) BTG4 Polyclonal antibody
Uniprot No.
Target Names
BTG4
Alternative Names
B cell translocation gene 4 antibody; BTG family member 4 antibody; Btg4 antibody; BTG4_HUMAN antibody; MGC33003 antibody; PC3B antibody; Protein BTG4 antibody; Protein PC3b antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human Protein BTG4 protein (1-206AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The BTG4 Antibody (Product code: CSB-PA878918LA01HU) is Non-conjugated. For BTG4 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA878918LB01HU BTG4 Antibody, HRP conjugated ELISA
FITC CSB-PA878918LC01HU BTG4 Antibody, FITC conjugated
Biotin CSB-PA878918LD01HU BTG4 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Adapter protein that bridges CNOT7, a catalytic subunit of the CCR4-NOT complex, to EIF4E. Facilitates maternal mRNAs decay during the maturation of oocytes and in the fertilized egg, and is required for the maternal-zygotic transition (MZT), zygotic cleavage and initiation of embryonic development.
Gene References into Functions
  1. BTG4 could contribute to chronic lymphocytic leykemia pathogenesis following inactivation by haploinsufficiency. PMID: 15672409
  2. miR-34b/c and BTG4 are novel tumor suppressors in colorectal cancer (CRC) and that the miR-34b/c CpG island, which bidirectionally regulates miR-34b/c and BTG4, is a frequent target of epigenetic silencing in CRC PMID: 18519671
  3. these data support BTG4 as a candidate tumor suppressor gene that is epigenetically silenced in the majority of gastric cancers. PMID: 19576178
Protein Families
BTG family
Tissue Specificity
Expressed in oocytes after germinal vesicle breakdown. Expressed in testis and in olfactory epithelium.
Database Links

HGNC: 13862

OMIM: 605673

KEGG: hsa:54766

STRING: 9606.ENSP00000348300

UniGene: Hs.128180

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*